TLX

MKT CAP:$3B

Telix Pharmaceuticals Limited

Market Cap

$3B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$9.22+$1.60 (+21.00%)

Jun 8, 2026

52W High $17.4652W Low $6.41

Company Details

Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals. The company operates through three segments: Precision Medicin...

CEO

—

IPO Date

Nov 14, 2024

Website

telixpharma.com

Key Metrics TTM

Revenue

$2.0B

+201.3% YoY

Net Income

$39M

EPS (Diluted)

Free Cash Flow

-$51M

Revenue / Share

$5.89

Gross Margin

56.4%

Operating Margin

5.4%

Net Margin

2.0%

FCF Margin

-2.6%

P/S

1.6x

P/E

81.4x

Earnings Reports

FY 2025

Feb 20, 2026

$1.2B+53.9%

Q4 2025

Feb 20, 2026

$620M+4.4%

Q2 2025

Aug 20, 2025

$593M+213.9%

FY 2024

Feb 24, 2025

$783M+55.8%

Q4 2024

Feb 24, 2025

$594M+110.9%

Revenue & Profitability

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee